Early invasive strategies for acute coronary syndromes
Martin J Quinn1, Sorin J Brener
1Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Desk F25, 9500 Euclid Avenue, OH 44195, USA.
Insights
Early invasive treatment for acute coronary syndromes (ACS) significantly reduces ischemic events and mortality. This strategy, involving angiography and revascularization, proves cost-effective despite initial higher costs due to fewer readmissions.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Acute coronary syndromes (ACS) require timely intervention.
- Early diagnosis and treatment are crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy and cost-effectiveness of an early invasive strategy for ACS.
- To assess the impact of coronary angiography and revascularization on ischemic outcomes.
Main Methods:
- Early coronary angiography followed by percutaneous or operative revascularization.
- Use of intracoronary stenting and intravenous glycoprotein IIb/IIIa antagonists.
- 1-year follow-up to assess ischemic outcomes, mortality, and readmissions.
Main Results:
- An early invasive strategy reduced ischemic outcomes by 18%–22% at 6 months for non-ST-segment elevation ACS.
- This approach prevented 1.7 deaths, 2.0 nonfatal infarcts, and 20 readmissions per 100 patients at 1 year.
- Improved outcomes with intracoronary stenting and glycoprotein IIb/IIIa antagonists in percutaneous coronary intervention (PCI).
Conclusions:
- Early angiography and revascularization are the preferred treatment for ACS.
- The early invasive strategy is cost-effective, offsetting initial costs through reduced hospitalizations.
- Assessment of coronary anatomy and left ventricular function aids in predicting long-term risk.
Abstract:
Early coronary angiography and percutaneous or operative revascularization is now the treatment of choice for both ST- and non-ST-segment elevation acute coronary syndromes (ACS). In non-ST-segment elevation ACS this strategy produces a 18% to 22% reduction in ischemic outcomes at 6 months and prevents 1.7 deaths, 2.0 nonfatal infarcts and 20 readmissions per 100 treated patients at 1-year follow-up. Early angiography allows definition of coronary anatomy and assessment of left ventricular function, both important predictors of long-term risk. Intracoronary stenting and intravenous glycoprotein IIb/IIIa antagonists have improved outcome in percutaneous revascularization and should be used in the majority of ACS patients undergoing PCI. Initial costs are higher with an early invasive strategy; however, these are offset by reductions in rehospitalizations and later ischemic complications.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Angina IV: Management


